Screener
Biogen BIIB Operating Lease ROU Assets
Operating Lease ROU Assets at other companies
Other financials
Where this comes from
Reported directly by Biogen in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.
The source filing: Biogen’s 10-Q, filed July 29, 2026.
- Filed
- Jul 29, 2026, 6:36 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000875045-26-000075
| Line item | As of June 30, 2026 | As of December 31, 2025 |
|---|---|---|
| Total current assets | 7,305.7 | 8,974.1 |
| Marketable securities | — | 431.9 |
| Property, plant and equipment, net | 2,994.1 | 3,055.4 |
| Operating lease assets | 245.7 | 265.4 |
| Intangible assets, net | 13,516.4 | 9,178.5 |
| Goodwill | 6,990.8 | 6,491.1 |
| Deferred tax asset | 202.1 | 292.5 |
| Investments and other assets | 831.8 | 750.6 |
Item 1. Financial Statements (unaudited)
FAQ
- What is Biogen's operating lease ROU assets?
- Biogen (BIIB) reported operating lease ROU assets of $245.7M in Q2 2026.
- How has Biogen's operating lease ROU assets changed year-over-year?
- Biogen's operating lease ROU assets decreased by 26.5% year-over-year, from $334.5M to $245.7M.
- What is the long-term trend for Biogen's operating lease ROU assets?
- Over 5 years (2020 to 2025), Biogen's operating lease ROU assets has grown at a 9724.3% compound annual growth rate (CAGR), from $0.03 to $265.4M.
- What does operating lease ROU assets mean?
- Right-of-use assets representing the lessee's right to use leased property over the lease term under ASC 842 operating lease classification.
Ask your AI about Biogen's operating lease rou assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude